MALAT1 expression in granulosa cells in PCOS patients with different phenotypes

Area of Science:

• Reproductive endocrinology
• Molecular biology
• Metabolic disorders

Background:

• Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting reproduction and metabolism.
• Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been implicated in reproductive system regulation.
• Previous studies on MALAT1 expression in PCOS granulosa cells (GCs) yielded inconsistent results.

Purpose of the Study:

• To investigate MALAT1 expression levels in GCs from PCOS patients across different subgroups.
• To assess the association between MALAT1 expression and PCOS phenotypes.
• To explore the potential role of MALAT1 in PCOS pathogenesis.

Main Methods:

• Quantitative PCR was used to examine MALAT1 expression in GCs from 110 PCOS cases and 71 controls.
• Statistical analyses were performed to correlate MALAT1 expression with clinical and endocrine parameters.
• Bioinformatic analysis of lncRNA target and PCOS-related databases was conducted.

Main Results:

• MALAT1 expression was significantly upregulated in PCOS GCs compared to controls.
• Upregulation was particularly pronounced in insulin-resistant (IR), obese, and non-hyperandrogenic (NHA) PCOS subgroups.
• MALAT1 expression correlated positively with BMI and metabolic parameters in controls, and with LH, FSH, E2, and LH/FSH ratio in PCOS patients.

Conclusions:

• MALAT1 exhibits differential expression in GCs of PCOS patients, especially in IR, obese, and NHA subgroups.
• MALAT1 may play a role in PCOS by influencing immune response and lipid metabolism within GCs.
• Further research is needed to fully elucidate the involvement of MALAT1 in PCOS.